Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Polsky, Daniel ^a,d   Bonafede, Machaon ^b   Suaya, Jose A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Thomson Reuters   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Asthma; Chronic Obstructive Pulmonary Disease (COPD); Community acquired pneumonia (CAP); Congestive Heart Failure (CHF); Diabetes; Economic evaluation; Medical cost; Productivity cost

Indexed keywords

ADULT; CASE CONTROL STUDY; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DIABETES MELLITUS; ECONOMICS; FEMALE; HEALTH CARE COST; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRENDS; UNITED STATES; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNICABLE DISEASE;

ADULT; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES;

EID: 84868246878     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-379     Document Type: Article

References (28)

1. Management of community-acquired pneumonia in the home: an American College of Chest Physicians clinical position statement. Ramsdell J, Narsavage GL, Fink J, Chest 2005 127 5 1752 1763 10.1378/chest.127.5.1752 15888856 (Pubitemid 46218805)
2. Incidence and cost of CAP in a large working-age population. Bonafede MM, Suaya JA, Wilson KL, Mannino DM, Polsky D, Am J Manag Care 2012 18 7 380 387 22823532
3. Asthma as a Risk Factor for Invasive Pneumococcal Disease. Talbot TR, Hartert TV, Mtchel E, et al. NEJM 2005 352 2082 2090 10.1056/NEJMoa044113 15901861 (Pubitemid 40667531)
4. Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia:A population-based case-control study. Kornum JB, Thomsen RW, Riis A, et al. Diabetes Care 2008 31 8 1541 1545 10.2337/dc08-0138 18487479
5. Reported Pneumonia in COPD: Findings From the INSPIRE Study. Calverley PMA, Stockley RA, Seemungal TAR, Chest 2010 139 3 483 485
6. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A, Am J Respir Crit Care Med 1999 160 397 405 10430704 (Pubitemid 29380648)
7. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Farr BM, Woodhead MA, Macfarlane JT, Bartlett CL, McCraken JS, Wadsworth J, Miller DL, Respir Med 2000 94 5 422 427 10.1053/rmed.1999.0743 10868703 (Pubitemid 30352997)
8. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G, Thorax 2009 64 1062 1069 10.1136/thx.2008.109785 19454409
9. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Rello J, Rodriguez A, Torres A, et al. Eur Respir J 2006 27 1210 1216 10.1183/09031936.06.00139305 16510452 (Pubitemid 44914306)
10. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. Thomsen RW, Kasatpibal N, Riis A, Nørgaard M, Sørensen HT, J Gen Intern Med 2008 23 9 1407 1413 Epub 2008 Jun 24 10.1007/s11606-008-0672-3 18574639
11. Cardiac Complications in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies. Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, et al. PLoS Med 2011 8 6 1001048 10.1371/journal.pmed.1001048 21738449
12. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA, Thorax 2009 64 3 ii1 iii55 10.1136/thx.2009.121434 19783532
13. Effect of early clopidogrel discontinuation on rehospitalization rate in acute coronary syndrome: Results from two distinct patient populations. Ernst FR, Johnston SS, Curkendall S, Mozaffari E, Stemkowski S, Am J Health Syst Pharm 2011 68 11 1015 1024 10.2146/ajhp100455 21593230
14. Real-world evaluation of healthcare resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine. Harnett J, Margolis J, Cao Z, Fowler R, Sanchez RJ, Mardekian J, Silverman SL, Pain Pract 2011 11 3 217 229 10.1111/j.1533-2500.2010.00440.x 21199319
15. The direct and indirect cost burden of acute coronary syndrome. Johnston SS, Curkendall S, Makenbaeva D, Mozaffari E, Goetzel R, Burton W, Maclean R, J Occup Environ Med 2011 53 1 2 7 10.1097/JOM.0b013e31820290f4 21187788
16. Costs of asthma among US working adults. Shenolikar R, Song X, Anderson JA, Chu BC, Cantrell CR, Am J Manag Care 2011 17 6 409 416 21756011
17. Health and productivity management-establishing key performance measures, benchmarks and best practices. Goetzel RZ, Guindon AM, Turshen IJ, Ozminkowski RJ, J Occup Env Med 2001 43 10 17 10.1097/00043764-200101000-00003 (Pubitemid 32098839)
18. National Average Wage Index, Social Security 2011 http://www.ssa.gov/ oact/cola/AWI.html#Series. Accessed September
19. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. Ozminkowski RJ, Burton WN, Goetzel RZ, Maclean R, Wang S, J Occup Environ Med 2006 48 135 148 10.1097/01.jom. 0000194161.12923.52 16474262 (Pubitemid 43237945)
20. Indirect Cost Burden of Migraine in the United States. Hawkins K, Wang S, Rupnow MFT, J Occup Environ Med 2007 49 368 374 10.1097/JOM.0b013e31803b9510 17426520 (Pubitemid 46624354)
21. COPD is associated with increased mortality in patients with community-acquired pneumonia. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A, Eur Respir J 2006 28 346 351 10.1183/09031936.06.00131905 16611653 (Pubitemid 44914234)
22. Economic burden of pneumonia in an employed population. Birnbaum HG, Morley M, Greenberg PE, Cifaldi M, Colice GL, Arch Intern Med 2001 161 2725 2731 10.1001/archinte.161.22.2725 11732939 (Pubitemid 33134850)
23. Treatment costs of community-acquired pneumonia in an employed population. Colice GL, Morley MA, Asche C, Birnbaum HG, Chest 2004 125 6 2140 2145 10.1378/chest.125.6.2140 15189934 (Pubitemid 38788182)
24. Determinants of hospital costs in community-acquired pneumonia. Reyes S, Martinez R, Valle's JM, Cases E, Menendez R, Eur Respir J 2008 31 1061 1067 10.1183/09031936.00083107 18448502
25. A population based study of the costs of care for community-acquired pneumonia. Bartolome M, Almirall J, Morera J, et al. Eur Respir J 2004 23 610 616 10.1183/09031936.04.00076704 15083763 (Pubitemid 38456006)
26. The cost of treating community-acquired pneumonia. Niederman MS, McCombs JI, Unger AN, Kumar A, Popovian R, Clin Ther 1998 20 820 837 10.1016/S0149-2918(98)80144-6 9737840 (Pubitemid 28421502)
27. Cost analyses of community acquired pneumonia from the hospital perspective. Bauer TT, Welte T, Ernen C, et al. Chest 2005 128 2238 2246 10.1378/chest.128.4.2238 16236880 (Pubitemid 41507565)
28. Hospitalized community acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT, Am J Respir Crit Care Med 2002 165 766 772 11897642 (Pubitemid 34229645)